Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PROMETRIUM 100 MG CAPSULE

Progesterone
$16.0175per EA
High Outlier

Strength

100 mg/1

Manufacturer

Acertis Pharmaceuticals, LLC

NDC

72989037230

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PROGESTERONE

Approval Type

New Drug (NDA)

FDA Application

NDA019781

On Market Since

11/1/2022

Pharmacological Classes

Progesterone
Progesterone

Price History

1W

0.0%

1M

-0.2%

3M

-0.2%

6M

+0.1%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

+0.5%

Generic Alternatives

Save up to 99%

6 alternatives • Same active ingredient

PROGESTERONE 100 MG CAPSULE
Generic
65162080710•Amneal Pharmaceuticals LLC
$0.2114
Save 99%
PROGESTERONE 100 MG CAPSULE
Generic
59651015201•Aurobindo Pharma Limited
$0.2114
Save 99%
PROGESTERONE 100 MG CAPSULE
Generic
43598034901•Dr. Reddy's Laboratories Inc.
$0.2114
Save 99%
PROGESTERONE 100 MG CAPSULE
Generic
16714015701•NorthStar Rx LLC
$0.2114
Save 99%
PROGESTERONE 100 MG CAPSULE
Generic
70700016201•Xiromed LLC
$0.2114
Save 99%
ENDOMETRIN 100 MG VAG INSERT
Brand
55566650003•Ferring Pharmaceuticals Inc.
$14.8738
Save 7%

Related Drugs

Same classification

BIJUVA 1 MG-100 MG CAPSULE
Brand
68308075030•Mayne Pharma
$8.1276
per EA
BIJUVA 0.5 MG-100 MG CAPSULE
Brand
68308075130•Mayne Pharma
$8.4287
per EA
CRINONE 4% GEL
Brand
00023615004•Allergan, Inc.
$16.8439
per GM
CRINONE 8% GEL
Brand
00023615108•Allergan, Inc.
$27.9228
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy